1. Home
  2. SEV vs STIM Comparison

SEV vs STIM Comparison

Compare SEV & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SEV

Aptera Motors Corp.

N/A

Current Price

$2.96

Market Cap

99.2M

Sector

Industrials

ML Signal

N/A

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.66

Market Cap

95.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEV
STIM
Founded
2019
2003
Country
United States
United States
Employees
46
N/A
Industry
Auto Manufacturing
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.2M
95.6M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SEV
STIM
Price
$2.96
$1.66
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
238.0K
2.0M
Earning Date
05-16-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.25
EPS
N/A
N/A
Revenue
N/A
$52,776,000.00
Revenue This Year
N/A
$11.10
Revenue Next Year
$17,757.14
$11.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.29
$0.80
52 Week High
$11.24
$4.84

Technical Indicators

Market Signals
Indicator
SEV
STIM
Relative Strength Index (RSI) 50.43 57.75
Support Level $2.37 $1.23
Resistance Level $3.26 $1.75
Average True Range (ATR) 0.24 0.18
MACD -0.00 0.02
Stochastic Oscillator 35.80 66.67

Price Performance

Historical Comparison
SEV
STIM

About SEV Aptera Motors Corp.

Aptera Motors Corp engages in the development, production, and distribution of energy efficient solar-powered, battery-electric vehicles. The company has designed the Aptera vehicle to provide up to an estimated 40 miles per day by collecting energy from the sun and storing it in its proprietary battery pack. The company operates as a single reportable segment focused on the development of solar electric vehicles.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: